Lidocaine Ointment USP 5% Recalled Due to cGMP Deviations
Teligent Pharma, Inc. is recalling Lidocaine Ointment USP 5% nationwide because the manufacturer is discontinuing its stability study program, which constitutes a deviation from current good manufacturing practice (cGMP). All products within their expiration dates are affected.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall with no reported illnesses or injuries. The hazard is a cGMP deviation (manufacturing practice deficiency) rather than a direct safety or efficacy threat. The source text does not report any adverse health events or patient harm, making this a precautionary recall based on regulatory non-compliance.
Plain-English summary
Teligent Pharma, Inc. is recalling Lidocaine Ointment USP, 5%, Net Wt 35.44 g (1 1/4 Oz) tubes manufactured for Hi-Tech Pharmacal Co., Inc. The recall applies to Batch 16695 with expiration date 4/30/2024. All products within their expiration dates are included in the recall.
The recall was initiated because the firm is discontinuing its stability study program, which represents a deviation from current good manufacturing practice (cGMP) standards required by the FDA for pharmaceutical manufacturing.
The product was distributed nationwide in the USA and Puerto Rico. Approximately 49,081 tubes are affected. The product is prescription only (Rx Only) and bears NDC 50383-341-35.
Consumers and healthcare providers who have this product should stop using it and consult with their pharmacist or healthcare provider about alternatives. Patients should not stop taking prescribed medication without medical guidance.
The recalled product
- Product
- Lidocaine Ointment USP, 5%, Net Wt 35.44 g (1 1/4 Oz) tube, Rx Only, Manufactured for: Hi-Tech Pharmacal Co., Inc., Amityville, NY 11701, NDC 50383-341-35.
- Manufacturer
- Teligent Pharma, Inc.
- Affected units
- 49,081
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Batch: 16695
- Exp 4/30/2024
Distribution
Part of a larger recall action
This product is one of 37 recalled by Teligent Pharma, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 37 products in this recall →Related recalls
Same manufacturer · Teligent Pharma, Inc.
See all →- ModerateDesonide Ointment Recalled Due to cGMP Deviations
FDA (Drugs) · 2022-03-30
- ModerateTriamcinolone Acetonide Cream USP 0.1% Recall — Stability Study Discontinuation
FDA (Drugs) · 2022-03-30
- ModerateTriamcinolone Acetonide Ointment Recalled Due to cGMP Deviations
FDA (Drugs) · 2022-03-30
- HighDiflorasone Diacetate Ointment recalled due to discontinued stability studies
FDA (Drugs) · 2022-03-30
- ModerateClobetasol Propionate Cream USP 0.05% Recall for cGMP Deviations
FDA (Drugs) · 2022-03-30
Same hazard · cgmp deviation
See all →- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Vancomycin Injection Due to CGMP Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09